Chemotherapy-induced peripheral neuropathy
- PMID: 15759068
- DOI: 10.1188/05.ONF.305-311
Chemotherapy-induced peripheral neuropathy
Abstract
Purpose/objectives: To review the literature documenting the scope, treatment, and prevention of chemotherapy-induced neuropathy.
Data sources: Published abstracts, primary research literature, and textbook chapters.
Data synthesis: Recent improvements in the management of other treatment-related toxicities have led to peripheral neuropathy becoming a dose-limiting toxicity of commonly used chemotherapeutic groups such as platinols, vinca alkaloids, and taxanes.
Conclusions: The nervous system has not been the focus of education or training for oncology nurses. Therefore, nurses' ability to educate patients regarding this aspect of their condition has been limited.
Implications for nursing: With its significant impact on quality of life, peripheral neuropathy treatment and prevention are important components in the care of patients with cancer.
Similar articles
-
Clinical challenges: chemotherapy-induced peripheral neuropathy.Semin Oncol Nurs. 2009 May;25(2 Suppl 1):S8-19. doi: 10.1016/j.soncn.2009.03.013. Semin Oncol Nurs. 2009. PMID: 19447319 Review.
-
Put evidence into practice to treat chemotherapy-induced peripheral neuropathy.ONS Connect. 2007 Dec;22(12):24-5. ONS Connect. 2007. PMID: 18161384 No abstract available.
-
Peripheral neuropathy related to chemotherapy.Semin Oncol Nurs. 2007 Aug;23(3):162-73. doi: 10.1016/j.soncn.2007.05.001. Semin Oncol Nurs. 2007. PMID: 17693343 Review.
-
Peripheral neuropathy: experimental findings, clinical approaches.J Support Oncol. 2007 Feb;5(2):61-3. J Support Oncol. 2007. PMID: 17354318 No abstract available.
-
Updating your peripheral neuropathy "know-how".Clin J Oncol Nurs. 2003 May-Jun;7(3):299-303. doi: 10.1188/03.CJON.299-303. Clin J Oncol Nurs. 2003. PMID: 12793336 Review.
Cited by
-
Neurotoxicity associated with cancer therapy.J Adv Pract Oncol. 2012 Jan;3(1):11-21. doi: 10.6004/jadpro.2012.3.1.2. J Adv Pract Oncol. 2012. PMID: 25031923 Free PMC article. Review.
-
Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy (CIPN) with Non-Pharmacological Interventions: Clinical Recommendations from a Systematic Scoping Review and an Expert Consensus Process.Med Sci (Basel). 2023 Jan 30;11(1):15. doi: 10.3390/medsci11010015. Med Sci (Basel). 2023. PMID: 36810482 Free PMC article.
-
Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency.Support Care Cancer. 2015 Jul;23(7):1843-50. doi: 10.1007/s00520-015-2725-6. Epub 2015 Apr 12. Support Care Cancer. 2015. PMID: 25863665 No abstract available.
-
Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy.Breast Cancer Res Treat. 2020 Apr;180(3):707-714. doi: 10.1007/s10549-020-05584-8. Epub 2020 Mar 12. Breast Cancer Res Treat. 2020. PMID: 32166478 Free PMC article.
-
Nurse self-evaluation of assessment of chemotherapy-induced peripheral neuropathy in patients with cancer.J Adv Pract Oncol. 2012 Sep;3(5):319-25. doi: 10.6004/jadpro.2012.3.5.5. J Adv Pract Oncol. 2012. PMID: 25031961 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical